Works well for me and conjunction with a healthy diet and exercise.* Was this helpful
Ozempic is FDA-approved for diabetes, Wegovy is FDA-approved for weight loss, and Rybelsus is an oral tablet FDA-approved for type 2 diabetes
Mounjaros active ingredient, tirzepatide, is known to target both GLP-1 and GIP receptors, which seems to be more effective than Ozempics active ingredient (semiglutide), which only targets GLP-1 receptors, great for certain conditions
Monitoring for Side Effects Common side effects of semaglutide include nausea, vomiting, and diarrhea
Unlike semaglutide, tirzepatide targets both GLP-1 and GIP (gastric inhibitory polypeptide) receptors, enhancing fat metabolism and insulin sensitivity
Based on PCSK9 binding data and manufacturability characteristics (i.e